Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Plos One|March 8, 2013
Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromesXiao Li, Zhi-jian Xiao, Chun-kang Chang, et al.
Leukemia Research|December 17, 2008
Multiple distinct clones may co-exist in different lineages in myelodysplastic syndromesWan-Ting Huang, Xiaorong Yang, Xiaobo Zhou, et al.
Human Pathology|February 25, 2017
RETRACTED: Downregulation of miR-204 expression correlates with poor clinical outcome of glioma patientsZhen-Nan Ye, Jing-Peng Liu, Ling-Yun Wu, et al.
Antioxidants & Redox Signaling|September 9, 2021
PDK4 Decrease Neuronal Apoptosis <i>via</i> Inhibiting ROS-ASK1/P38 Pathway in Early Brain Injury After Subarachnoid HemorrhageXuan Gao, Yong-Yue Gao, Hui-Ying Yan, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 12, 2018
The rise of soluble platelet-derived growth factor receptor β in CSF early after subarachnoid hemorrhage correlates with cerebral vasospasmJing-Peng Liu, Zhen-Nan Ye, Sheng-Yin Lv, et al.
Cell Calcium|September 20, 2025
MICU1 attenuates neuronal apoptosis after subarachnoid hemorrhage by inhibiting mitochondrial calcium overload and damageJie Wang, Yue Cui, Peng-Fei Ding, et al.
American Journal of Translational Research|March 25, 2017
Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromesZheng Zhang, Qi He, Ying Tao, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Supervised learning of high-confidence phenotypic subpopulations from single-cell dataTao Ren, Canping Chen, Alexey V Danilov, et al.
Behavioural Neurology|July 5, 2018
Biochanin A Reduces Inflammatory Injury and Neuronal Apoptosis following Subarachnoid Hemorrhage via Suppression of the TLRs/TIRAP/MyD88/NF-<i>κ</i>B PathwayLing-Yun Wu, Zhen-Nan Ye, Zong Zhuang, et al.
Scientific Reports|December 5, 2014
Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndromeFeng Xu, Qi He, Xiao Li, et al.
Pageof 16